This paper mainly studied the extraction process of traditional Chinese medicine Aristolochia mollissima Hance (Aristolochiaceae) and the inhibitory effect of its extracts on osteosarcoma HOS cells. The extraction process included the ultrasonic extraction method, heat reflux method and decoction method to obtain three different extracts. MTT assay was used to test the effect of the extracts on proliferation of HOS cells, to compare the degree of inhibitory activity of three extracts, and to calculate cell survival rates. The results showed that among the three extracts obtained by the ultrasonic extraction method, heat reflux method and decoction method, the one obtained by ultrasonic extraction has the largest yield, but the extract obtained by heat reflux method has the strongest anticancer activity. Nevertheless, the three extracts all have a good inhibitory activity on the proliferation of osteosarcoma HOS cells.
Results
Weight of extracts obtained by three extraction methods (Table 1) The weight of extract obtained by heat reflux method was 1.23 g, and the weight of extract obtained by ultrasonic extraction was 1. 
Study on HOS cell proliferation inhibitory activity by MTT assay
The MTT assay results showed that the extract obtained by heat reflux method had the most obvious inhibitory effect, and the inhibition rate increased with the increase in time and concentration. The inhibitory effects by decoction method and ultrasonic extraction method were relatively poor, yet the effects somewhat existed. The inhibitory activity of extract A obtained by heat reflux method is shown in Table 2 
Figure 2: Inhibitory activities of different extracts after 24 h of action
As can be seen from the figure, the extract obtained by heat reflux method has the best inhibitory activity and lower cell survival rate, where cell survival rate reduced to about 60% within 24h. The HOS cell proliferation inhibitory effects of the extracts obtained by three methods were generally higher, where the inhibition rates of extracts obtained by ultrasonic extraction and decoction methods were also around 70%.
Discussion
Osteosarcoma is a malignant disease of mesenchymal tissue origin, which often occurs among young people. Pathological sites are generally in the metaphysis. It has high early incidence of haematogenous metastasis which is rapidly progressing as well. Commonly used therapeutic methods include surgery, gene therapy, immunotherapy, chemotherapy and molecularly targeted therapy. The repair and reconstruction surgery of the surgical therapy can provide a variety of repair means for limb salvage, and thus have gained wide applications.
A gene drug for the treatment of osteosarcoma is the recombinant human endostatin (rh-Endostatin), which is a specific multi-target vascular endothelial cell growth inhibitor. It has an inhibitory effect on human endothelial cell migration, and can specifically inhibit the tumour neovascular
